ST6GAL1-IN-1, CAS [[192876-13-4]]

Produktübersicht

• Artikelname: ST6GAL1-IN-1, CAS [[192876-13-4]]
• Artikelnummer: MCE-HY-173496
• Hersteller Artikelnummer: HY-173496
• Alternativnummer: MCE-HY-173496-10MG,MCE-HY-173496-50MG,MCE-HY-173496-100MG,MCE-HY-173496-5MG,MCE-HY-173496-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

ST6GAL1-IN-1 is an orally active selective ST6GAL1 inhibitor (IC50 = 20 µM). ST6GAL1-IN-1 exhibits high antimetastatic potential, effectively inhibiting the migration of MDA-MB-231 cells at noncytotoxic concentrations. ST6GAL1-IN-1 can disrupt integrin sialylation in MDA-MB-231 cells. ST6GAL1-IN-1 inhibits tumor angiogenesis and cancer metastasis via the Integrin/VEGFR2-mediated signaling pathway. ST6GAL1-IN-1 effectively suppresses both tumor growth and cancer metastasis on the MDA-MB-231 xenograft model. ST6GAL1-IN-1 can be used for the study of Triple-negative breast cancer (TNBC)[1].

Produkteigenschaften

• Molekulargewicht: 562.78
• Reinheit: 99.22
• CAS Nummer: [192876-13-4]
• Formel: C35H50N2O4
• Target-Kategorie: Akt,Integrin,Sialyltransferase,VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound